背侧前扣带回脑深部电刺激治疗难治性丘脑痛综合征
该研究评估背侧前扣带回(ACC)脑深部电刺激(DBS)治疗药物难治性丘脑痛综合征(TPS)的有效性与安全性。2015年1月至2017年4月共5例患者接受ACC DBS,术后6个月NRS评分改善37.9%,18个月改善35%,McGill、EuroQol5-domain及SF-36评分亦见改善,无手术或刺激相关并发症。结论认为ACC DBS可能安全且有前景,需更大规模随机研究验证。
要点
- ACC DBS可使难治性TPS患者NRS评分6个月改善37.9%、18个月改善35%。
- 术后McGill、EuroQol5-domain及SF-36评分均见改善。
- 研究期间无手术或刺激相关并发症发生。
核心结论
- ACC DBS可能安全且有前景,可减轻药物难治性TPS患者的不适并改善整体生活质量。
- 需进一步前瞻性、更大规模及随机研究验证这些发现。
研究设计与样本
- 2015年1月至2017年4月,5例纯药物难治性TPS患者在本机构接受ACC DBS。
- 术前1天及术后6、18个月采用NRS、SF-36、McGill疼痛问卷和EuroQol5-domain问卷进行定量评估。
主要发现
- 手术平均年龄56.2岁(范围47-66)。
- NRS评分6个月改善37.9%(范围-22.2%至-80%),18个月改善35%(范围-11.1%至-80%)。
- 末次随访时1例患者疼痛明显减轻(NRS 2),仅诉轻度疼痛,对日常生活活动干扰小。
- 每次随访均观察到McGill和EuroQol5-domain疼痛问卷、SF-36总分及子项评分 concomitant 改善。
- 研究期间无手术或刺激相关并发症发生。
临床怎么用
- 对于药物难治性丘脑痛综合征,ACC DBS可作为改善疼痛及生活质量的候选手术选项。
- 术后需采用NRS、SF-36、McGill及EuroQol5-domain问卷进行多维度随访评估。
局限性
- 样本量小(5例),需更大规模前瞻性随机研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuroimaging evidences and previous successful case series of cingulotomy for cancer pain have disclosed the key-role of the dorsal anterior cingulate cortex (ACC) in the generation of the empathic and affective dimension of pain. The aim of this study is to assess the effectiveness and safety of ACC neuromodulation for the treatment of the thalamic pain syndrome (TPS), a chronic neuropathic disease often complicated by severe affective and emotional distress in the long term. METHOD: From January 2015 to April 2017, 5 patients with pure drug-refractory TPS underwent ACC deep brain stimulation (DBS) at our institution. Quantitative assessment of pain and health-related quality of life were performed 1 day before surgery and postoperatively at 6 and 18 months by using the numeric rating scale (NRS), the 36-item short-form health survey (SF-36), and the McGill pain and the EuroQol5-domain questionnaires. RESULTS: Mean age at surgery was 56.2 years (range, 47-66). NRS score improved by 37.9% at 6 months (range, - 22.2 to - 80%) and by 35% at 18 months (range, - 11.1 to - 80%). At the last follow-up, one patient reported a relevant pain reduction (NRS 2), only complaining of mild pain poorly interfering with activities of daily living. Concomitant improvements in the McGill and EuroQol5-domain pain questionnaires, SF-36 total and sub-item scores were also noticed at each follow-up. No surgical or stimulation-related complications occurred during the study period. CONCLUSIONS: ACC DBS may be a safe and promising surgical option to alleviate discomfort and improve the overall quality of life in a patient affected by drug-resistant TPS. Further prospective, larger, and randomized studies are needed to validate these findings.
引用
- Levi V, Cordella R, D'Ammando A, et al. Dorsal anterior cingulate cortex (ACC) deep brain stimulation (DBS): a promising surgical option for the treatment of refractory thalamic pain syndrome (TPS). Acta Neurochir (Wien). 2019. PMID: 31209628. doi:10.1007/s00701-019-03975-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。